Life sciences companies are racing to deploy AI, but the real differentiator will not be model sophistication. It will be the ability to turn fragmented commercial data into trusted, contextualized intelligence that can drive decisions at scale.

As the industry moves from generative AI experimentation to agentic, workflow-integrated intelligence, the pressure is rising. AI does not solve fragmented data. It exposes it. Without a governed semantic foundation, AI systems can accelerate ambiguity, reinforce inconsistent definitions, and produce outputs leaders cannot confidently operationalize.

The organizations that win will be those that can connect first-party, third-party, and partner data into a common commercial intelligence layer that is AI-ready, domain-aware, secure, and built for action.

Ready to dive deeper? Read the full insight brief.